Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 296 results for "zydus group cadila healthcare"

Zydus gets USFDA nod to sell morphine sulfate tablets
DNA India

Cadila Healthcare gains after receiving market authorisation f...

Cadila Healthcare rose 1.29% to Rs 1,820 at 15:15 IST on BSE after the company said the Zydus group has received the market authorisation from the United States Food & Drug Administration to market Morphine Sulfate ER tablet. The company made announcement ... Business Standard, 3 days ago
[x]  

8 images for zydus group cadila healthcare

India Infoline, 1 week ago
India Infoline, 1 month ago
Times of India, 1 month ago
India Infoline, 3 months ago
Money Control, 3 months ago
Odisha Samaya, 3 months ago
India Infoline, 3 months ago
Business Standard India, 4 months ago

Cadila Health up 3%, Zydus to market pain killer drug in US

Shares of Cadila Healthcare climbed 3 percent intraday Wednesday after the Zydus group allowed to market its strong pain killer drug in the US. "The Zydus group has received the market authorisation from the US Food and Drug Administration (USFDA) ...
 Moneycontrol.com3 days ago Cadila Healthcare up 3% on USFDA nod for neurological drug  Moneycontrol.com1 week ago

Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 crore

Mumbai: Cadila Healthcare, the Zydus Cadilla Group flagship, has emerged as the frontrunner to acquire the generic sterile injectables business of Ahmedabad-headquartered Claris Lifesciences Ltd (CLL) trumping several domestic and global peers who ...
 India Brand Equity Foundation1 month ago Cadila Healthcare eyes Claris arm for Rs 3,400 crore  Economic Times1 month ago Buy Cadila Healthcare; tgt of Rs 1920: Firstcall Research  Moneycontrol.com1 month ago Cadila Healthcare trumps peers, in talks to acquire Claris Lifesciences for whooping Rs 3,400 crore  Business Insider India1 month ago

Zydus Cadila Q4 net up 46%; revenues jump 16%

Related to : Zydus Wellness Ltd,Cadila Healthcare Ltd Zydus Wellness Ltd BSE 15 May 15 | 03:34 PM 970.00 -30.9 (-3.09%) NSE 15 May 15 | 03:40 PM 971.20 -29.15 (-2.91%) Ahmedabad-based drug major Cadila Healthcare Ltd, has posted ...
 Smart Investor1 month ago Cadila Healthcare consolidated net surges by 46% in Q4, dividend at 240%  PharmaBiz1 month ago Zydus Cadila Q4 net profit up 46%  Livemint.com1 month ago

Zydus to Present New Scientific Data on Lipaglyn (Saroglitazar), and Real World Data in Patients With Type 2 Diabetes at the American Diabetes Association 75th Scientific Sessions in Boston, USA

/PRNewswire/ -- Zydus Cadila, a leading global healthcare provider, today announced that new scientific and clinical data on Saroglitazar will be presented at the 75th Annual Scientific Sessions of the American Diabetes Association (ADA) in ...
 Barchart4 weeks ago
[x]  
Moneycontrol.com

Cadila Healthcare to delist from Ahmedabad Stock Exchange, will remain listed on BSE and NSE

NEW DELHI: Cadila Healthcare has decided to delist its shares from Ahmedabad Stock Exchange (ASE) in view of non-trading of the company's shares on the exchange for past many years. The company's board, which met today, decided to delist equity ...
 Economic Times3 weeks ago Cadila to delist from Ahmedabad Stock Exchange  DeshGujarat3 weeks ago

Coal India, BS and Cadila Healthcare to see some action today

SENSEX 27802.00 35.21 0.13% NIFTY 8408.10 15.15 0.18% Industries: Airlines/Aviation, Metal and Mining, ...
 Finalaya.com1 month ago

Cadila to seek shareholders' nod to raise up to Rs 10,000 crore

NEW DELHI: Cadila Healthcare plans to seek "an enabling approval" from its shareholders to raise up to Rs 10,000 crore via issue of different securities. The company's board, which met today, decided to seek shareholders' nod to issue of securities keeping in ...
 Economic Times2 months ago

Pieris Pharmaceuticals to Present Data on Novel Anti-CD137 and HER2 Bispecific Immuno-Oncology Program at UBS Global Healthcare Conference

) - Pieris Pharmaceuticals, Inc . ( OTCQB: PIRS ), a biotechnology company advancing its proprietary Anticalin ® biotherapeutic technologies, announced today that President and CEO, Stephen Yoder, will present preclinical data on a new ...
 RCL Advisors1 month ago PIERIS PHARMACEUTICALS : to Present Data on Novel Anti-CD137 and HER2 Bispecific Immuno-Oncology Program at UBS Global Healthcare Conference  4 Traders1 month ago Pieris Pharmaceuticals, Inc. (PIRS: OTCQB) | Pieris Pharmaceuticals to Present at the 2015 UBS Global Healthcare Conference on May 19th, 2015  OTC Markets1 month ago Pieris Pharmaceuticals to Present at the 2015 UBS Global Healthcare Conference on May 19th, 2015  MoneyShow.com1 month ago
[x]  

Zydus ties up with US-based research centre to develop vaccine

Pharmaceuticals major Zydus today said that its R&D subsidiary Etna Biotech will collaborate with US-based National Institute of Allergy and Infectious Diseases (NIAD) to develop a vaccine against visceral leishmaniasis (VL), known as Kala-Azar in India. Etna ...
 The Financial Chronicle2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus group cadila healthcare
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less